Joseph Sinkule

Founder, Chief Executive Officer, Director and Chairman of the Board of Greenland Mines Ltd. (Nasdaq: GRML), the company formerly known as Klotho Neurosciences, Inc. Over 40 years of drug, biologic and medical device R&D and commercialization experience, having personally managed more than 8 drug and biotech products through FDA approval to market, plus 5 medical devices and 8 in vitro diagnostics. Serves on multiple boards and consults for venture capital firms and pharmaceutical companies. Confirmed as CEO by his signature on the company's 8-K filed 11 September 2026. Sources: greenlandmines.com/about/, ir.greenlandmines.com board page, and SEC 8-K.